Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSEN1 | P49768 | 11/20 | 0.51 |
| ▸ | PSEN2 | P49810 | 11/20 | 0.51 |
| ▸ | APH1B | Q8WW43 | 11/20 | 0.51 |
| ▸ | NCSTN | Q92542 | 11/20 | 0.51 |
| ▸ | APH1A | Q96BI3 | 11/20 | 0.51 |
| ▸ | PSENEN | Q9NZ42 | 11/20 | 0.51 |
| ▸ | SPPL2A | Q8TCT8 | 1/20 | 0.51 |
| ▸ | GSAP | A4D1B5 | 1/20 | 0.46 |
| ▸ | NOTCH1 | P46531 | 2/20 | 0.42 |
| ▸ | NOTCH3 | Q9UM47 | 2/20 | 0.42 |
| ▸ | CCKBR | P32239 | 4/20 | 0.40 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7685573 | 0.86 | PSEN1 (0.47) | PSEN1PSEN2APH1BNCSTNAPH1A | |
| SCHEMBL7687284 | 0.85 | PSEN1 (0.44) | PSEN1PSEN2APH1BNCSTNAPH1A | |
| SCHEMBL6301946 | 0.81 | CCKBR (0.46) | PSEN1PSEN2APH1BNCSTNAPH1A | |
| SCHEMBL4414767 | 0.77 | CCKBR (0.47) | PSEN1PSEN2APH1BNCSTNAPH1A | |
| SCHEMBL30934892 | 0.77 | CCKBR (0.47) | PSEN1PSEN2APH1BNCSTNAPH1A | |
| SCHEMBL25314617 | 0.77 | PSEN1 (0.75) | PSEN1PSEN2APH1BNCSTNAPH1A | |
| SCHEMBL16417117 | 0.77 | PSEN1 (0.75) | PSEN1PSEN2APH1BNCSTNAPH1A | |
| SCHEMBL29404290 | 0.77 | PSEN1 (0.75) | PSEN1PSEN2APH1BNCSTNAPH1A | |
| SCHEMBL33527945 | 0.77 | PSEN1 (0.75) | PSEN1PSEN2APH1BNCSTNAPH1A | |
| SCHEMBL4413298 | 0.77 | PSEN1 (0.75) | PSEN1PSEN2APH1BNCSTNAPH1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020111343-A1 | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-Amyloid peptide release and/or its synthesis by use of such compounds | WU JING (US) | 2002-08-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020111343-A1 | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-Amyloid peptide release and/or its synthesis by use of such compounds | BACE1, APP, BACE2 | PSEN1 6/4885PSEN2 9/4885APH1B 4/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.